Rankings
▼
Calendar
▼
INBS Q2 2019 Earnings Report — Intelligent Bio Solutions Inc. Revenue & Financial Results | Market Cap Arena
Intelligent Bio Solutions Inc.
INBS
Q2 2019 Earnings
Reported December 31, 2018
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q2 2019
Q1 2019
Q2 2018
QoQ Change
YoY Change
Revenue
$0
—
$0
—
—
Op. Income
-$602.0K
—
-$1M
—
56.0%
EPS (Diluted)
$-375.90
—
$-436.90
—
14.0%
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$64.6K
Selling & Marketing
$6.4K
General & Administrative
$531.4K
SG&A Expenses
$537.8K
Other Expenses
$0
Operating Expenses
$602.4K
Cost & Expenses
$602.4K
OPERATING INCOME
-$602.0K
Interest Income
$0
Interest Expense
$167.0K
Other Income/Expenses
-$719.0K
INCOME BEFORE TAX
-$1M
Income Tax Expense
$0
Net Income from Continuing Ops
-$1M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$1M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$1M
D&A
$602.4K
EBIT
-$602.0K
EBITDA
$0
EPS
-$376
EPS Diluted
-$376
marketcaparena.com
← FY 2019
INBS Overview
Q3 2019 →